share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:拟议出售证券
美股sec公告 ·  07/10 16:45
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 07/10/2024, with an aggregate market value of $108,575.69. The shares were acquired through stock option exercises on 06/13/2023 and 06/14/2023, with a total of 15,000 shares obtained from the issuer for a cash payment. This planned sale follows a series of transactions over the past three months, where a total of 93,124 shares were sold for gross proceeds of approximately $755,664.65.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 07/10/2024, with an aggregate market value of $108,575.69. The shares were acquired through stock option exercises on 06/13/2023 and 06/14/2023, with a total of 15,000 shares obtained from the issuer for a cash payment. This planned sale follows a series of transactions over the past three months, where a total of 93,124 shares were sold for gross proceeds of approximately $755,664.65.
Recursion Pharmaceuticals, Inc.的高管Secora Michael计划于2024年7月10日出售15000 Class A股,总市值达到$108,575.69。这些股票是通过2023年6月13日和6月14日两次行权方式获取的,股票发行方以现金方式售出了总共15000股。这次预计出售是在过去三个月内一系列交易之后进行的。在这期间进行了总共93124股的卖出,总收益约为$755,664.65。
Recursion Pharmaceuticals, Inc.的高管Secora Michael计划于2024年7月10日出售15000 Class A股,总市值达到$108,575.69。这些股票是通过2023年6月13日和6月14日两次行权方式获取的,股票发行方以现金方式售出了总共15000股。这次预计出售是在过去三个月内一系列交易之后进行的。在这期间进行了总共93124股的卖出,总收益约为$755,664.65。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息